InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Lask Alisa, 董事. Director active across 2 companies, notably NEPHROS INC. Aggregated, 6 disclosures have been logged. Activity tracked since 14 December 2021. The latest transaction was disclosed on 13 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Lask Alisa is Administrateur at NEPHROS INC and RVL Pharmaceuticals plc. She has 6 filings in total, and the sampled recent filings run from 2021-12-16 to 2023-12-15, with the modal transaction nature shown as Attribution. In those recent filings, both buy and sell amounts are 0, and the largest listed filing is for RVL Pharmaceuticals plc on 2023-08-14 for EUR 5354.387045263962.